Exelixis
EXEL
#1344
Rank
A$24.04 B
Marketcap
A$98.52
Share price
-3.60%
Change (1 day)
51.73%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Sustainability Reports

Thumbnail Exelixis Sustainability Report 2025

Sustainability Report 2025

Language: English

View Sustainability Report
Thumbnail Exelixis Sustainability Report 2024

Sustainability Report 2024

Language: English

View Sustainability Report
Thumbnail Exelixis Sustainability Report 2023

Sustainability Report 2023

Language: English

View Sustainability Report
Thumbnail Exelixis Sustainability Report 2022

Sustainability Report 2022

Language: English

View Sustainability Report